Organogenesis Holdings Inc.
ORGO
$2.61
$0.030.97%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 563.03M | 464.62M | 429.31M | 458.76M | 482.04M |
| Total Other Revenue | 1.14M | 603.00K | 226.00K | -- | -- |
| Total Revenue | 564.17M | 465.22M | 429.53M | 458.76M | 482.04M |
| Cost of Revenue | 137.52M | 118.66M | 109.20M | 110.77M | 115.74M |
| Gross Profit | 426.65M | 346.56M | 320.33M | 347.99M | 366.30M |
| SG&A Expenses | 325.72M | 299.40M | 291.97M | 294.70M | 294.51M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 507.78M | 463.84M | 444.08M | 453.57M | 460.53M |
| Operating Income | 56.39M | 1.38M | -14.55M | 5.19M | 21.52M |
| Income Before Tax | 46.97M | -6.20M | -21.54M | -24.25M | -2.81M |
| Income Tax Expenses | 9.94M | -7.21M | -13.31M | -8.37M | -3.67M |
| Earnings from Continuing Operations | 37.03 | 1.01 | -8.23 | -15.88 | 0.86 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 37.03M | 1.01M | -8.23M | -15.88M | 861.00K |
| EBIT | 56.39M | 1.38M | -14.55M | 5.19M | 21.52M |
| EBITDA | 74.98M | 19.56M | 3.17M | 22.53M | 38.54M |
| EPS Basic | 0.16 | -0.07 | -0.10 | -0.16 | -0.01 |
| Normalized Basic EPS | 0.29 | 0.02 | -0.07 | 0.02 | 0.10 |
| EPS Diluted | 0.12 | -0.08 | -0.10 | -0.17 | -0.02 |
| Normalized Diluted EPS | 0.25 | 0.01 | -0.07 | 0.02 | 0.09 |
| Average Basic Shares Outstanding | 506.95M | 509.72M | 515.41M | 521.12M | 526.69M |
| Average Diluted Shares Outstanding | 524.96M | 516.17M | 519.24M | 524.96M | 530.52M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |